{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05704036",
            "orgStudyIdInfo": {
                "id": "IRB00307525"
            },
            "organization": {
                "fullName": "Johns Hopkins University",
                "class": "OTHER"
            },
            "briefTitle": "Estrogen Supplementation and Bone Health in Women With CF",
            "officialTitle": "Estrogen Supplementation and Bone Health in Women With CF (STURDY)",
            "acronym": "STURDY",
            "therapeuticArea": [
                "Other"
            ],
            "study": "estrogen-supplementation-and-bone-health-in-women-with-cf"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-02",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-01-10",
            "studyFirstSubmitQcDate": "2023-01-19",
            "studyFirstPostDateStruct": {
                "date": "2023-01-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-21",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Johns Hopkins University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Cystic Fibrosis Foundation",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this study is to learn about the role of estrogen and other hormones in bone development in adolescent and young adult women with cystic fibrosis (CF). The study has two main components, an observational study and a feasibility sub-study. The main questions it aims to answer are:\n\n* How do different forms of hormonal contraception (e.g. birth control pill or other progesterone only methods) impact bone health?\n* Is a study of transdermal estradiol (estrogen skin patches) feasible in this group?\n* How does transdermal estradiol impact bone health and quality of life?\n\nParticipants in the observational study will have three study visits (baseline, 6 months, and 12 months). At all visits, participants will have blood drawn and will complete questionnaires. At the baseline and 12 month visits, participants will additionally have x-rays and DXAs (bone density assessment). Between visits, participants will complete brief questionnaires. Researchers will compare various measurements over time to assess the impact of different forms of hormonal contraception.\n\nParticipants in the feasibility sub-study will apply transdermal estradiol patches once weekly for 12 months, fill out brief quality-of-life surveys in between study visits, and complete blood draws and questionnaires at four study visits (baseline, 3 months, 6 months, and 12 months). The participants will also have x-rays and DXAs performed at the baseline and 12 month visits. Researchers will examine changes in various measurements to determine the impact of transdermal estradiol."
        },
        "conditionsModule": {
            "conditions": [
                "Cystic Fibrosis",
                "Hypoestrogenism"
            ],
            "keywords": [
                "Bone Mineral Density",
                "Osteoporosis",
                "Young Adult",
                "Adolescent",
                "Premenopause",
                "Estradiol",
                "Bone Disease",
                "Bone Diseases, Metabolic",
                "Hormones",
                "Quality of Life"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 75,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Observational Study",
                    "type": "NO_INTERVENTION",
                    "description": "Participants will complete three study visits (baseline, 6 months, and 12 months) involving DXAs (bone density assessment), x-rays, blood draws, and questionnaires."
                },
                {
                    "label": "Transdermal Estradiol/Cyclic Progesterone",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will apply transdermal estradiol patches (0.1 mg/day) weekly for 12 months following baseline study visits. Participants not already using a progesterone-containing contraceptive will also take progesterone (200 mg) for 10 days per month.",
                    "interventionNames": [
                        "Drug: Transdermal estrogen",
                        "Drug: Progesterone"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Transdermal estrogen",
                    "description": "Transdermal estradiol 0.1 mg/day, applied once weekly",
                    "armGroupLabels": [
                        "Transdermal Estradiol/Cyclic Progesterone"
                    ],
                    "otherNames": [
                        "Transdermal estradiol",
                        "Climara"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Progesterone",
                    "description": "Progesterone 200 mg daily for 10 days/month, if participant is not on progesterone-containing contraceptive",
                    "armGroupLabels": [
                        "Transdermal Estradiol/Cyclic Progesterone"
                    ],
                    "otherNames": [
                        "Prometrium"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in lumbar spine bone mineral density assessed by dual-energy x-ray absorptiometry (DXA)",
                    "timeFrame": "Baseline and 12 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in serum procollagen type I intact N-terminal propeptide (P1NP) levels (mcg/L)",
                    "description": "P1NP is a marker of bone turnover.",
                    "timeFrame": "Baseline and 12 months"
                },
                {
                    "measure": "Change in serum C-terminal telopeptide of type I collagen (CTX-1) levels (pg/mL)",
                    "description": "CTX-1 is a marker of bone turnover.",
                    "timeFrame": "Baseline and 12 months"
                },
                {
                    "measure": "Change in quality of life as assessed by Cystic Fibrosis Respiratory Symptom Diary - Chronic Respiratory Infection Symptom Score (CFRSD-CRISS) questionnaire",
                    "description": "CFRSD-CRISS is a brief survey to assess quality of life of people with cystic fibrosis that will be taken by participants twice per month. The questionnaire is scored from 0-100 with higher scores indicating increased symptom severity.",
                    "timeFrame": "Baseline and 12 months"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Study procedure completion rate",
                    "description": "Percentage of participants enrolled in study who complete all study procedures.",
                    "timeFrame": "Evaluated at completion of study, approximately two years"
                },
                {
                    "measure": "Acceptability as determined by participant report",
                    "description": "Acceptability during study participation by 5 point Likert scale, with a score or 3 or greater considered acceptable.",
                    "timeFrame": "Across 12 months of study participation per participant"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Observational Study:\n\nInclusion Criteria:\n\n* CF Diagnosis\n* Females who have had at least 1 menstrual cycle\n* Planning to use same formulation of estrogen supplementation (or none) for duration of study\n\nExclusion Criteria:\n\n* Use of anti-osteoporosis therapy including anti-resorptives such as bisphosphonates or anabolic agents such as teriparatide or denosumab\n* Conditions in which bone loss is known to be present or expected to occur, such as lactation\n* Pregnant or planning to become pregnant\n* In the opinion of the CF care team or study investigators participant should not participate in the study\n* Inability to provide informed consent/assent\n\nFeasibility Sub-Study:\n\nInclusion Criteria:\n\n* All of above and\n* \\<35 years old\n* At least 2 years after first menstrual cycle\n* Symptoms of low estrogen and/or low serum estradiol levels (\\< 50 pg/mL)\n\nExclusion Criteria:\n\n* All of above and\n* Contraindications to transdermal estradiol\n* Current use of systemic estrogen (such as estrogen-containing oral contraceptive pill)\n* Previous lung or liver transplant\n* Use of chronic systemic glucocorticoids\n* Severe vitamin D deficiency (serum 25(OH)D \\< 6 ng/mL)\n* Conditions increasing risk of clot: history of previous deep vein thrombus or pulmonary embolism, current immobility, current peripherally inserted central catheter or mediport, known hypercoagulable condition\n* Baseline study visit falls between 1 and 8 weeks after initiation of CF transmembrane receptor (CFTR) modulator\n* Currently in pulmonary exacerbation\n* Recent antibiotic use within the past 4 weeks for an acute pulmonary exacerbation\n* Unwilling or unable to use a non-estrogen containing method of contraception such as barrier, abstinence, or progesterone-only method",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "0 Years",
            "maximumAge": "100 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sara Malina",
                    "role": "CONTACT",
                    "phone": "443-287-8997",
                    "email": "smalina1@jh.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Malinda Wu, MD, MSc",
                    "affiliation": "Johns Hopkins University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Johns Hopkins",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21287",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sara Malina",
                            "role": "CONTACT",
                            "phone": "443-287-8997",
                            "email": "smalina1@jh.edu"
                        },
                        {
                            "name": "Malinda Wu, MD, MSc",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003550",
                    "term": "Cystic Fibrosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010182",
                    "term": "Pancreatic Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000007232",
                    "term": "Infant, Newborn, Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6755",
                    "name": "Cystic Fibrosis",
                    "asFound": "Cystic Fibrosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8485",
                    "name": "Fibrosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M12947",
                    "name": "Osteoporosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M5130",
                    "name": "Bone Diseases, Metabolic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5126",
                    "name": "Bone Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13102",
                    "name": "Pancreatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M10276",
                    "name": "Infant, Newborn, Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T1710",
                    "name": "Cystic Fibrosis",
                    "asFound": "Cystic Fibrosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T6034",
                    "name": "Quality of Life",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000004958",
                    "term": "Estradiol"
                },
                {
                    "id": "D000004967",
                    "term": "Estrogens"
                },
                {
                    "id": "D000011374",
                    "term": "Progesterone"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000011372",
                    "term": "Progestins"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M14245",
                    "name": "Progesterone",
                    "asFound": "Region",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8116",
                    "name": "Estrogens",
                    "asFound": "USA",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6494",
                    "name": "Contraceptive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M266279",
                    "name": "Estradiol 17 beta-cypionate",
                    "relevance": "LOW"
                },
                {
                    "id": "M266280",
                    "name": "Estradiol 3-benzoate",
                    "relevance": "LOW"
                },
                {
                    "id": "M8108",
                    "name": "Estradiol",
                    "asFound": "Cell lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M234941",
                    "name": "Polyestradiol phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M14244",
                    "name": "Progestins",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Repr",
                    "name": "Reproductive Control Agents"
                }
            ]
        }
    },
    "hasResults": false
}